Drug intelligence / Profile preview

eruca sativa extract R1

Development stage
Preclinical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Eruca sativa extract R1 is a botanical extract derived from the rocket plant (*Eruca sativa*), specifically investigated for its potential in managing obesity and metabolic disorders. The extract is rich in nitrates and isothiocyanates, which act as precursors for nitric oxide (NO) and hydrogen sulfide (H2S), respectively. Preclinical studies indicate that R1 attenuates body weight gain, reduces white adipose tissue mass, and decreases adipocyte size. Its molecular mechanism involves the downregulation of Diacylglycerol O-acyltransferase 2 (DGAT2) and Peroxisome proliferator-activated receptor gamma (PPARγ), which are critical regulators of lipid synthesis and adipogenesis. Additionally, the extract has shown efficacy in improving liver steatosis in high-fat diet models, though it does not appear to influence glucose tolerance or blood pressure.

Other names
rocket extractEruca sativa extract
02

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)DGAT2 (Hepatic diacylglycerol acyltransferase 2)

Beyond the preview

Go deeper on eruca sativa extract R1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on eruca sativa extract R1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call